{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:04:57Z","timestamp":1789596297817,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T00:00:00Z","timestamp":1531353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00520-018-4340-9","type":"journal-article","created":{"date-parts":[[2018,7,12]],"date-time":"2018-07-12T01:04:03Z","timestamp":1531357443000},"page":"531-538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3794-1344","authenticated-orcid":false,"given":"Jennifer L.","family":"Moss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia L.","family":"Filiaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lari B.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Minasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Temkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,12]]},"reference":[{"key":"4340_CR1","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","volume":"384","author":"GC Jayson","year":"2014","unstructured":"Jayson GC, Kohn EC, Kitchener HC, Ledermann JA (2014) Ovarian cancer. Lancet 384:1376\u20131388","journal-title":"Lancet"},{"key":"4340_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jogn.2017.04.134","volume":"46","author":"J Keim-Malpass","year":"2017","unstructured":"Keim-Malpass J, Mihalko SL, Russell G, Case D, Miller B, Avis NE (2017) Problems experienced by ovarian cancer survivors during treatment. J Obstet Gynecol Neonatal Nurs 46:544\u2013554","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"4340_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1006\/gyno.1995.0014","volume":"59","author":"AB Kornblith","year":"1995","unstructured":"Kornblith AB, Thaler HT, Wong G, Vlamis V, McCarthylepore J, Loseth DB et al (1995) Quality of life of women with ovarian cancer. Gynecol Oncol 59:231\u2013242","journal-title":"Gynecol Oncol"},{"key":"4340_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s11764-016-0525-8","volume":"10","author":"D Ahmed-Lecheheb","year":"2016","unstructured":"Ahmed-Lecheheb D, Joly F (2016) Ovarian cancer survivors\u2019 quality of life: a systematic review. J Cancer Surviv 10:789\u2013801","journal-title":"J Cancer Surviv"},{"key":"4340_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ygyno.2017.05.008","volume":"146","author":"SK Lutgendorf","year":"2017","unstructured":"Lutgendorf SK, Shinn E, Carter J, Leighton S, Baggerly K, Guindani M, Fellman B, Matzo M, Slavich GM, Goodman MT, Tew W, Lester J, Moore KM, Karlan BY, Levine DA, Sood AK (2017) Quality of life among long-term survivors of advanced stage ovarian cancer: a cross-sectional approach. Gynecol Oncol 146:101\u2013108","journal-title":"Gynecol Oncol"},{"key":"4340_CR6","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ygyno.2016.12.005","volume":"144","author":"KM Doll","year":"2017","unstructured":"Doll KM, Pinheiro LC, Reeve BB (2017) Pre-diagnosis health-related quality of life, surgery, and survival in women with advanced epithelial ovarian cancer: a SEER-MHOS study. Gynecol Oncol 144:348\u2013353","journal-title":"Gynecol Oncol"},{"key":"4340_CR7","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1158\/1078-0432.CCR-16-1119","volume":"22","author":"EV Bandera","year":"2016","unstructured":"Bandera EV, Lee VS, Rodriguez-Rodriguez L, Powell CB, Kushi LH (2016) Racial\/ethnic disparities in ovarian cancer treatment and survival. Clin Cancer Res 22:5909\u20135914","journal-title":"Clin Cancer Res"},{"key":"4340_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ygyno.2014.03.561","volume":"134","author":"RE Bristow","year":"2014","unstructured":"Bristow RE, Chang J, Ziogas A, Anton-Culver H, Vieira VM (2014) Spatial analysis of adherence to treatment guidelines for advanced-stage ovarian cancer and the impact of race and socioeconomic status. Gynecol Oncol 134:60\u201367","journal-title":"Gynecol Oncol"},{"key":"4340_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/jnci\/djt065","volume":"105","author":"RE Bristow","year":"2013","unstructured":"Bristow RE, Powell MA, Al-Hammadi N, Chen L, Miller JP, Roland PY et al (2013) Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst 105:823\u2013832","journal-title":"J Natl Cancer Inst"},{"key":"4340_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ygyno.2011.11.025","volume":"125","author":"M Terplan","year":"2012","unstructured":"Terplan M, Schluterman N, McNamara EJ, Tracy JK, Temkin SM (2012) Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol 125:19\u201324","journal-title":"Gynecol Oncol"},{"key":"4340_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/jamaoncol.2014.161","volume":"1","author":"C Zeng","year":"2015","unstructured":"Zeng C, Wen W, Morgans AK, Pao W, Shu X-O, Zheng W (2015) Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program in the United States, 1990 to 2010. JAMA Oncol 1:88\u201396","journal-title":"JAMA Oncol"},{"key":"4340_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.envres.2017.03.057","volume":"156","author":"VM Vieira","year":"2017","unstructured":"Vieira VM, Villanueva C, Chang J, Ziogas A, Bristow RE (2017) Impact of community disadvantage and air pollution burden on geographic disparities of ovarian cancer survival in California. Environ Res 156:388\u2013393","journal-title":"Environ Res"},{"key":"4340_CR13","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.ejca.2008.02.001","volume":"44","author":"A Jones","year":"2008","unstructured":"Jones A, Haynes R, Sauerzapf V, Crawford S, Zhao H, Forman D (2008) Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. Eur J Cancer 44:992\u2013999","journal-title":"Eur J Cancer"},{"key":"4340_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ejca.2007.07.028","volume":"44","author":"A Jones","year":"2008","unstructured":"Jones A, Haynes R, Sauerzapf V, Crawford S, Zhao H, Forman D (2008) Travel times to health care and survival from cancers in Northern England. Eur J Cancer 44:269\u2013274","journal-title":"Eur J Cancer"},{"key":"4340_CR15","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1634\/theoncologist.2015-0110","volume":"20","author":"M Ambroggi","year":"2015","unstructured":"Ambroggi M, Biasini C, Del Giovane C, Fornari F, Cavanna L (2015) Distance as a barrier to cancer diagnosis and treatment: review of the literature. Oncologist 20:1378\u20131385","journal-title":"Oncologist"},{"key":"4340_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ygyno.2015.03.010","volume":"137","author":"SM Temkin","year":"2015","unstructured":"Temkin SM, Fleming SA, Amrane S, Schluterman N, Terplan M (2015) Geographic disparities amongst patients with gynecologic malignancies at an urban NCI-designated cancer center. Gynecol Oncol 137:497\u2013502","journal-title":"Gynecol Oncol"},{"key":"4340_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.healthpol.2012.02.016","volume":"105","author":"MA Tanke","year":"2012","unstructured":"Tanke MA, Ikkersheim DE (2012) A new approach to the tradeoff between quality and accessibility of health care. Health Policy 105:282\u2013287","journal-title":"Health Policy"},{"key":"4340_CR18","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","volume":"365","author":"RA Burger","year":"2011","unstructured":"Burger RA, Brady MF, Bookman MA, Fleming GF, Monk BJ, Huang H, Mannel RS, Homesley HD, Fowler J, Greer BE, Boente M, Birrer MJ, Liang SX, Gynecologic Oncology Group (2011) Incorporation of bevacizumab in the primary treatment of ovarian cancer. N Engl J Med 365:2473\u20132483","journal-title":"N Engl J Med"},{"key":"4340_CR19","unstructured":"U.S. Census Bureau (2018) American FactFinder. \n                    https:\/\/factfinder.census.gov\/faces\/nav\/jsf\/pages\/index.xhtml\n                    \n                  . Accessed 2017"},{"key":"4340_CR20","first-page":"1013","volume":"99","author":"VL Shavers","year":"2007","unstructured":"Shavers VL (2007) Measurement of socioeconomic status in health disparities research. J Natl Med Assoc 99:1013","journal-title":"J Natl Med Assoc"},{"key":"4340_CR21","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1200\/JCO.2001.19.6.1809","volume":"19","author":"K Basen-Engquist","year":"2001","unstructured":"Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA, Webster K, Cella D, Hu S, Gershenson DM (2001) Reliability and validity of the functional assessment of cancer therapy\u2013ovarian. J Clin Oncol 19:1809\u20131817","journal-title":"J Clin Oncol"},{"key":"4340_CR22","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1177\/107755879505200406","volume":"52","author":"CS Phibbs","year":"1995","unstructured":"Phibbs CS, Luft HS (1995) Correlation of travel time on roads versus straight line distance. Med Care Res Rev 52:532\u2013542","journal-title":"Med Care Res Rev"},{"key":"4340_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ygyno.2016.09.026","volume":"143","author":"G Mishkin","year":"2016","unstructured":"Mishkin G, Minasian LM, Kohn EC, Noone A-M, Temkin SM (2016) The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies. Gynecol Oncol 143:611\u2013616","journal-title":"Gynecol Oncol"},{"key":"4340_CR24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ygyno.2012.11.038","volume":"128","author":"BJ Monk","year":"2013","unstructured":"Monk BJ, Huang HQ, Burger RA, Mannel RS, Homesley HD, Fowler J, Greer BE, Boente M, Liang SX, Wenzel L (2013) Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study. Gynecol Oncol 128:573\u2013578","journal-title":"Gynecol Oncol"},{"key":"4340_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/IGC.0b013e3181dad379","volume":"20","author":"T Luckett","year":"2010","unstructured":"Luckett T, King M, Butow P, Friedlander M, Paris T (2010) Assessing health-related quality of life in gynecologic oncology: a systematic review of questionnaires and their ability to detect clinically important differences and change. Int J Gynecol Cancer 20:664\u2013684","journal-title":"Int J Gynecol Cancer"},{"key":"4340_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/aje\/kwf068","volume":"156","author":"N Krieger","year":"2002","unstructured":"Krieger N, Chen JT, Waterman PD, Soobader M-J, Subramanian S, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The public health disparities geocoding project. Am J Epidemiol 156:471\u2013482","journal-title":"Am J Epidemiol"},{"key":"4340_CR27","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ygyno.2011.11.032","volume":"124","author":"VE Gruenigen Von","year":"2012","unstructured":"Von Gruenigen VE, Huang HQ, Gil KM, Frasure HE, Armstrong DK, Wenzel LB (2012) The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group Study. Gynecol Oncol 124:379\u2013382","journal-title":"Gynecol Oncol"},{"key":"4340_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/BF00635619","volume":"1","author":"S Nayfield","year":"1992","unstructured":"Nayfield S, Ganz P, Moinpour C, Cella D, Hailey B (1992) Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials. Qual Life Res 1:203\u2013210","journal-title":"Qual Life Res"},{"key":"4340_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ygyno.2017.07.121","volume":"147","author":"N Phippen","year":"2017","unstructured":"Phippen N, Secord A, Wolf S, Samsa G, Davidson B, Abernethy A et al (2017) Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: an ancillary data analysis of the NRG Oncology\/Gynecologic Oncology Group (GOG-0218) study. Gynecol Oncol 147:98\u2013103","journal-title":"Gynecol Oncol"},{"key":"4340_CR30","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMp1709816","volume":"377","author":"K Baicker","year":"2017","unstructured":"Baicker K, Chandra A (2017) Evidence-based health policy. N Engl J Med 377:2413\u20132415","journal-title":"N Engl J Med"},{"key":"4340_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1196\/annals.1425.007","volume":"1136","author":"C Hoffman","year":"2008","unstructured":"Hoffman C, Paradise J (2008) Health insurance and access to health care in the United States. Ann N Y Acad Sci 1136:149\u2013160","journal-title":"Ann N Y Acad Sci"},{"key":"4340_CR32","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1200\/JCO.2014.55.6258","volume":"32","author":"GV Walker","year":"2014","unstructured":"Walker GV, Grant SR, Guadagnolo BA, Hoffman KE, Smith BD, Koshy M, Allen PK, Mahmood U (2014) Disparities in stage at diagnosis, treatment, and survival in nonelderly adult patients with cancer according to insurance status. J Clin Oncol 32:3118\u20133125","journal-title":"J Clin Oncol"},{"key":"4340_CR33","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/pon.3133","volume":"22","author":"CS Eom","year":"2013","unstructured":"Eom CS, Shin DW, Kim SY, Yang HK, Jo HS, Kweon SS, Kang YS, Kim JH, Cho BL, Park JH (2013) Impact of perceived social support on the mental health and health-related quality of life in cancer patients: results from a nationwide, multicenter survey in South Korea. Psycho-Oncology 22:1283\u20131290","journal-title":"Psycho-Oncology"},{"key":"4340_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/cam4.84","volume":"2","author":"X Niu","year":"2013","unstructured":"Niu X, Roche LM, Pawlish KS, Henry KA (2013) Cancer survival disparities by health insurance status. Cancer Med 2:403\u2013411","journal-title":"Cancer Med"},{"key":"4340_CR35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1200\/JCO.2014.55.3107","volume":"33","author":"JL Warren","year":"2015","unstructured":"Warren JL, Butler EN, Stevens J, Lathan CS, Noone A-M, Ward KC, Harlan LC (2015) Receipt of chemotherapy among Medicare patients with Cancer by type of supplemental insurance. J Clin Oncol 33:312\u2013318","journal-title":"J Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4340-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4340-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4340-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T19:12:56Z","timestamp":1562872376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4340-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,12]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4340"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4340-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,12]]},"assertion":[{"value":"7 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript was prepared or accomplished by the authors in their personal capacity. The opinions expressed in this article are the authors\u2019 own and do not reflect the view of the National Institutes of Health, the Department of Health and Human Services, or the US government. The statements presented in this publication are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors, or its Methodology Committee. Original data are maintained by NRG Oncology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}